DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $38,315,040 | -58.7% | 159,646 | -56.6% | 0.19% | -62.0% |
| Q1 2023 | $92,728,540 | +174.8% | 367,912 | +189.4% | 0.50% | +159.3% |
| Q4 2022 | $33,747,357 | +16606.6% | 127,147 | +16117.7% | 0.19% | +19300.0% |
| Q3 2022 | $202,000 | -98.9% | 784 | -98.7% | 0.00% | -98.9% |
| Q1 2022 | $18,223,000 | -8.5% | 62,125 | +2.6% | 0.09% | -8.2% |
| Q4 2021 | $19,917,000 | +33.6% | 60,535 | +23.6% | 0.10% | +24.4% |
| Q3 2021 | $14,910,000 | -72.7% | 48,974 | -75.9% | 0.08% | -71.9% |
| Q2 2021 | $54,594,000 | -4.3% | 203,435 | -19.7% | 0.28% | -12.6% |
| Q1 2021 | $57,037,000 | -10.0% | 253,406 | -11.2% | 0.32% | -15.0% |
| Q4 2020 | $63,389,000 | +110.0% | 285,357 | +103.5% | 0.37% | +86.1% |
| Q3 2020 | $30,187,000 | +145.0% | 140,191 | +101.2% | 0.20% | +131.0% |
| Q2 2020 | $12,319,000 | +112.9% | 69,663 | +84.8% | 0.09% | +117.5% |
| Q4 2019 | $5,786,000 | -67.3% | 37,700 | -79.0% | 0.04% | -60.0% |
| Q2 2018 | $17,696,000 | -49.1% | 179,325 | -49.5% | 0.10% | -52.4% |
| Q1 2018 | $34,758,000 | +7.2% | 355,000 | +1.6% | 0.21% | +11.1% |
| Q4 2017 | $32,436,000 | -10.7% | 349,450 | -17.5% | 0.19% | -13.3% |
| Q3 2017 | $36,321,000 | +85.1% | 423,425 | +82.1% | 0.22% | +69.0% |
| Q2 2017 | $19,625,000 | +330.5% | 232,550 | +336.3% | 0.13% | +330.0% |
| Q1 2017 | $4,559,000 | +46.9% | 53,300 | +34.6% | 0.03% | +36.4% |
| Q3 2016 | $3,104,000 | +1291.9% | 39,600 | +1423.1% | 0.02% | +1000.0% |
| Q2 2015 | $223,000 | +0.9% | 2,600 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $221,000 | -0.9% | 2,600 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $223,000 | – | 2,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |